France : Sanofi : Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency

Press/Media

Period3 Feb 2020

Media coverage

1

Media coverage

  • TitleFrance : Sanofi : Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency
    Media name/outletTendersInfo – News
    Country/TerritoryIndia
    Date3/02/20
    PersonsMelissa Wasserstein